Ishara Investments LP
LOS ANGELES, CA · CIK 2111609 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2024 · limited partnership
- Assets managed$259.1m
- Staff6 · 5 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $19.9m gross assets
- Websiteisharainvestments.com
- Form ADV · 2026-03-19SEC adviser record
- Legal entityISHARA INVESTMENTS LP (US)
- Kindhedge funds
- Others nearbyLos Angeles, CA
As an employer
- Offices in1 country
- Private fundshedge 1
$136.1m
reported value
+37.4% vs Q1 2026
41positions
51.0%in top 10
16 new
13 added
8 reduced
11 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ACADIA PHARMACEUTICALS INC ACAD | $10.4m7.62% | Added +287.0k |
| XERIS BIOPHARMA HOLDINGS INC XERS | $9.7m7.16% | Added +205.0k |
| BIOMARIN PHARMACEUTICAL INC BMRN | $8.2m6.03% | Added +61.5k |
| PRAXIS PRECISION MEDICINES I PRAX | $7.5m5.55% | Unchanged |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $6.8m5.03% | Added +30.8k |
| AGIOS PHARMACEUTICALS INC AGIO | $6.1m4.47% | New |
| INSMED INC INSM | $5.5m4.01% | New |
| CRINETICS PHARMACEUTICALS IN CRNX | $5.4m3.95% | New |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $5.0m3.65% | Reduced -205.0k |
| VAXCYTE INC PCVX | $4.8m3.50% | Added +24.6k |
| ANNEXON INC ANNX | $4.7m3.44% | Added +645.8k |
| TRAVERE THERAPEUTICS INC TVTX | $4.7m3.42% | Reduced -28.7k |
| TONIX PHARMACEUTICALS HLDG C TNXP | $4.3m3.17% | New |
| BRIDGEBIO PHARMA INC BBIO | $4.3m3.14% | New |
| AXSOME THERAPEUTICS INC AXSM | $4.0m2.95% | Reduced -24.6k |
| CONTINEUM THERAPEUTICS INC CTNM | $3.4m2.47% | Added +63.0k |
| LEXICON PHARMACEUTICALS INC LXRX | $3.1m2.24% | Added +369.0k |
| KURA ONCOLOGY INC KURA | $3.0m2.23% | New |
| DBV TECHNOLOGIES S A DBVT | $3.0m2.22% | Added +82.0k |
| GENMAB A/S GMAB | $2.8m2.07% | Added +20.5k |
| CYTOKINETICS INC CYTK | $2.8m2.05% | New |
| MINERALYS THERAPEUTICS INC MLYS | $2.8m2.03% | Added +20.5k |
| SILENCE THERAPEUTICS PLC SLN | $2.4m1.79% | Reduced -85.2k |
| NUVATION BIO INC NUVB | $2.1m1.54% | New |
| WAVE LIFE SCIENCES LTD 96663EUR | $1.9m1.40% | New |
| NEKTAR THERAPEUTICS NKTR | $1.9m1.37% | New |
| SCHOLAR ROCK HLDG CORP SRRK | $1.7m1.24% | Reduced -26.6k |
| ENLIVEN THERAPEUTICS INC ELVN | $1.7m1.22% | New |
| ALNYLAM PHARMACEUTICALS INC ALNY | $1.5m1.13% | Unchanged |
| BEAM THERAPEUTICS INC BEAM | $1.4m1.03% | Reduced -16.4k |
| SIONNA THERAPEUTICS INC SION | $1.4m0.99% | Added +73.8k |
| ORIC PHARMACEUTICALS INC ORIC | $1.3m0.98% | Added +20.5k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $1.3m0.92% | Unchanged |
| VERTEX PHARMACEUTICALS INC VRTX | $1.2m0.90% | New |
| ARS PHARMACEUTICALS INC SPRY | $1.1m0.84% | New |
| MONOPAR THERAPEUTICS INC MNPR | $1.1m0.84% | New |
| ERASCA INC ERAS | $751.1k0.55% | New |
| VERA THERAPEUTICS INC VERA | $439.8k0.32% | Reduced -71.8k |
| IMMATICS N.V IMTX | $311.5k0.23% | Reduced -123.0k |
| MEREO BIOPHARMA GROUP PLC MREO | $244.2k0.18% | New |
| GOSSAMER BIO INC GOSS | $135.0k0.10% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| KALVISTA PHARMACEUTICALS INC KALV | $5.6m276.8k shares |
| AMICUS THERAPEUTICS INC FOLD | $5.3m369.0k shares |
| VERASTEM INC VSTM | $4.3m820.0k shares |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $3.5m55.4k shares |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $3.2m174.2k shares |
| ARDELYX INC ARDX | $2.7m451.0k shares |
| CATALYST PHARMACEUTICALS INC CPRX | $2.0m82.0k shares |
| LIGAND PHARMACEUTICALS INC LGND | $1.6m8.2k shares |
| EDGEWISE THERAPEUTICS INC EWTX | $1.5m49.2k shares |
| IDEAYA BIOSCIENCES INC IDYA | $819.7k24.6k shares |
| PTC THERAPEUTICS INC PTCT | $698.3k10.2k shares |